B
Bausch Health Companies Inc. (BHC)
NYQ – Real Time Price. Currency in USD
5.41
+0.04 (0.74%)
At close: May 12, 2026, 4:00 PM EDT
5.44
+0.03 (0.55%)
After-hours: May 12, 2026, 7:48 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NYQ – Real Time Price. Currency in USD
5.41
+0.04 (0.74%)
At close: May 12, 2026, 4:00 PM EDT
5.44
+0.03 (0.55%)
After-hours: May 12, 2026, 7:48 PM EDT
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
| Name | Position |
|---|---|
| Mr. Cees Heiman | Senior Vice President of Europe & Canada |
| Mr. Garen Sarafian | VP & Head of Investor Relations |
| Mr. Jean-Jacques Charhon | Executive VP & CFO |
| Mr. Mirza Dautbegovic | Executive VP & COO |
| Mr. Steven H. Lee | Senior VP, Controller & Chief Accounting Officer |
| Mr. Thomas J. Appio | CEO & Director |
| Date | Type | Document |
|---|---|---|
| 2026-04-30 | 10-Q | bhc-20260331.htm |
| 2026-04-29 | 8-K | bhc-20260429.htm |
| 2026-04-08 | DEFA14A | ny20055690x2_defa14a.htm |
| 2026-04-08 | DEF 14A | ny20055690x1_def14a.htm |
| 2026-03-02 | 8-K | d938319d8k.htm |
| 2026-02-19 | 10-K | bhc-20251231.htm |
| 2026-02-18 | 8-K | bhc-20260218.htm |
| 2026-01-23 | 8-K | bhc-20260123.htm |
| 2026-01-13 | 8-K | bhc-20260113.htm |
| 2026-01-02 | 8-K | dp239511_8k.htm |
| Ms. Aimee J. Lenar | Executive Vice President of US Pharma |
| Ms. Jiny Kim M.B.A. | Senior Vice President of Solta Medical |
| Ms. Kathleen Fitzpatrick | Executive VP and Chief HR & Communications Officer |
| Ms. Seana Carson | Executive VP & General Counsel |